Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	-77.98	32.30	146.70
Graham Fair Price	197.15	0.03	0.01
PEG	-100.00	-0.10	0.00
Price/Book	-66.51	1.54	4.61
Price/Cash Flow	84.75	-5.55	-36.39
Prices/Earnings	84.75	-50.80	-333.00
Price/Sales	-84.75	4.02	26.36
Price/FCF	84.75	-5.55	-36.39
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	-8.24	0.82	0.90
Operating Margin	< 0.005	0.09	0.09
ROA	-119.55	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-119.55
ROIC	< 0.005	< 0.005	119.55
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	0.00	0.00	0.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.00	1.20	100.00
EPS QOQ	0.00	-5.00	-100.00
FCF QOQ	0.00	-1.20	-100.00
Revenue QOQ	0.00	1.20	100.00
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	2498.33	78.50	-96.86
Days Sales Outstanding (DSO)	954.26	0.00	inf
Inventory Turnover	0.04	1.15	3082.60
Debt/Capitalization	0.59	0.59	0.00
Quick Ratio	0.50	0.01	-97.80
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	0.04	0.07	100.55
Cash	< 0.005	< 0.005	100.55
Capex	0.00	0.00	0.00
Free Cash Flow	< 0.005	-0.02	-340.30
Revenue	< 0.005	0.03	340.30
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	0.67	0.67	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	34.20	15.37	-55.06
Naive Interpretation	Member

06 - Financial Health · Bad

Rating